WHO Censorship Tactics Should be Exposed at World Health Assembly

Food and Healthcare Press Releases Tuesday May 24, 2016 13:35
GENEVA--24 May--PRNewswire/InfoQuest
  • As the Annual Summit Takes Place This Week, Global Leaders Have an Opportunity toScrutinize WHO's definition of transparency and accountability

Health Ministers from 194 countries will gather this week in Geneva to set the direction for future health policy around the world. JTI - Japan Tobacco International - is calling for the Assembly to urgently address an alarming transparency and accountability crisis at the heart of the World Health Organization (WHO) during discussions on the agency's reform.

(Logo: http://photos.prnewswire.com/prnh/20130528/617491 )

In a recent report, the WHO states that "...significant progress has been made towards meeting the objectives of being a more effective, efficient, transparent and accountable organization."[1] This contradicts censorship practices that are increasingly being witnessed at WHO meetings.

At the last Conference of the Parties (COP6) of the WHO's Framework Convention on Tobacco Control (FCTC) in 2014, members of the public and journalists were unjustifiably ejected from the public gallery, leaving them unable to observe and report on plenary sessions that are meant to be transparent. The alarming tactic of conducting proceedings behind closed doors has prompted concerns - notably by the media - that health lobbyists and non-elected parties are wielding undue influence over treaty negotiations.

These exclusion tactics go against basic transparency and accountability rules - and are in sharp contrast to other UN meetings. At the Sustainable Innovation Forum (COP21) on climate change in Paris earlier this year, some 3000 journalists were accredited, while political and business leaders from around the world actively participated in debates. Proceedings were open to the public and live-streamed on the internet. Businesses sponsored the event.

Michiel Reerink, Global Regulatory Strategy Vice-President at JTI, stated: "Nobody would argue against the need for tobacco to be appropriately regulated, but there is a right way and a wrong way of achieving that. Excluding the public and the media from debates amounts to censorship, and is unacceptable from a publicly-funded organization. This begs the question: what does the WHO have to hide?"

JTI, a member of the Japan Tobacco Group of Companies, is a leading international tobacco manufacturer. It markets world-renowned brands such as Winston, Camel, Mevius and LD. Other global brands include Benson & Hedges, Silk Cut, Sobranie and Glamour. With headquarters in Geneva, Switzerland, and about 26,000 employees worldwide, JTI has operations in more than 120 countries. Its core revenue in the fiscal year ended December 31, 2015, was USD 10.3 billion. For more information, visit http://www.jti.com.

--------------------------------------------------
1. Overview of reform implementation, World Health Organization, Report by the Director General, Sixty-ninth World Health Assembly, Provisional agenda item 11.1, March 11, 2016, p.1.
Source: JTI (Japan Tobacco International)

Latest Press Release

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook

Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem...

MEDICAL WINGS THAILAND BASED AIR AMBULANCE OPERATOR ACHIEVES FULL ACCREDITATION FROM CAMTS AND CAMTS EU AND BECOMES THE FIRST OPERATOR IN ASIA TO ACHIEVE THE #DUAL ACCREDITATION

Medical Wings, the air ambulance division of Siam Land Flying Company, a subsidiary company of Charoen Pokphand Group (C.P. Group), is proud to achieve full re-accreditation of its existing CAMTS approval as well as attaining the new CAMTS EU...

Photo Release: CGH Group Hospital held the event Happy Life with Healthy Bone and Joints Seminar in Yangon, Myanmar.

CGH Group Hospital recently held a live health talk in Yangon, Myanmar to highlight the important health issues on bone and joints for all Myanmar people. A team of medical experts led by Dr. Wanchai Sirisereewan (4th from left), CGH's Orthopedic Surgeon...

BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study

- First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a regulatory submission in the US and...

Related Topics